T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.57B |
| 2 |
Elevance Health
ELV
|
+$1.16B |
| 3 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$1.01B |
| 4 |
Royal Caribbean
RCL
|
+$860M |
| 5 |
AET
Aetna Inc
AET
|
+$790M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$1.76B |
| 2 |
Biogen
BIIB
|
+$1.47B |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$1.26B |
| 4 |
McKesson
MCK
|
+$1.2B |
| 5 |
Sherwin-Williams
SHW
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.75% |
| 2 | Consumer Discretionary | 14.84% |
| 3 | Financials | 13.9% |
| 4 | Technology | 11.11% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STFC
626
DELISTED
State Auto Financial Corp
STFC
| $81.8M | 0.02% |
3,587,029
+653,404
| +22% | +$16M |
|
627
Innospec
IOSP
$2.31B
| $81.5M | 0.02% |
1,752,638
-879,407
| -33% | -$40.3M |
|
628
Intuit
INTU
$98B
| $81.5M | 0.02% |
918,439
+19,522
| +2% | +$1.89M |
|
629
RPC Inc
RES
$1.39B
| $81.3M | 0.02% |
9,188,415
+3,223,290
| +54% | +$36.8M |
|
|
PHH
630
DELISTED
PHH Corporation
PHH
| $80.6M | 0.02% |
5,709,466
+11,100
| +0.2% | +$217K |
|
|
FNSR
631
DELISTED
Finisar Corp
FNSR
| $80.3M | 0.02% |
7,216,965
+2,083,370
| +41% | +$32.6M |
|
632
New York Times
NYT
$10.3B
| $79.9M | 0.02% |
6,767,691
-3,502,909
| -34% | -$44.2M |
|
633
Liberty Latin America Class C
LILAK
$1.65B
| $79.8M | 0.02% |
+2,723,115
| New | +$92.2M |
|
|
CVT
634
DELISTED
CVENT, INC.
CVT
| $79.6M | 0.02% |
2,365,891
-1,005,528
| -30% | -$30.4M |
|
635
Progress Software
PRGS
$1.83B
| $79.5M | 0.02% |
3,079,497
-217,160
| -7% | -$6.15M |
|
|
JOY
636
DELISTED
Joy Global Inc
JOY
| $79.5M | 0.02% |
5,324,689
+101,810
| +2% | +$2.47M |
|
|
ISEE
637
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $78.5M | 0.02% |
1,936,814
-74,594
| -4% | -$3.95M |
|
638
Adobe
ADBE
$108B
| $78.1M | 0.02% |
950,416
+50,739
| +6% | +$4.11M |
|
639
Veeco
VECO
$3.28B
| $78.1M | 0.02% |
3,806,802
+1,170,580
| +44% | +$28.3M |
|
640
Grupo Aval
AVAL
$6.41B
| $78M | 0.02% |
10,182,810
+1,565,200
| +18% | +$12.8M |
|
|
XLRN
641
DELISTED
Acceleron Pharma
XLRN
| $77.8M | 0.02% |
3,125,001
-22,642
| -0.7% | -$681K |
|
642
Littelfuse
LFUS
$11.4B
| $77.4M | 0.02% |
849,330
-87,880
| -9% | -$8M |
|
643
Southern Company
SO
$107B
| $77.2M | 0.02% |
1,726,822
+29,500
| +2% | +$1.29M |
|
|
BFS
644
Saul Centers
BFS
$865M
| $76.7M | 0.02% |
1,482,240
+153,930
| +12% | +$7.85M |
|
645
Belden
BDC
$5.36B
| $76.6M | 0.02% |
1,640,653
-92,100
| -5% | -$5.43M |
|
646
VF Corp
VFC
$5.79B
| $76.5M | 0.02% |
1,191,025
+458,174
| +63% | +$31.4M |
|
647
AZZ Inc
AZZ
$4.52B
| $76.2M | 0.02% |
1,564,039
+100,060
| +7% | +$5.14M |
|
648
Avient
AVNT
$4.23B
| $76.1M | 0.02% |
2,593,850
+1,464,590
| +130% | +$49.5M |
|
649
General Dynamics
GD
$106B
| $75.9M | 0.02% |
550,479
-8,925
| -2% | -$1.29M |
|
650
Columbia Banking Systems
COLB
$9.18B
| $75.9M | 0.02% |
2,431,710
-18,060
| -0.7% | -$571K |
|
Similar funds
T. Rowe Price Associates's Q3 2015 Portfolio in Review
As of Q3 2015, T. Rowe Price Associates held 2,618 positions worth $449B, down 7.6% from $486B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q3 2015 filing shows 86 new, 1,108 increased, 800 reduced and 108 closed positions. Its largest new stake was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M. The largest sale was Baidu, an estimated $1.76B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2015 buy was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M.
- T. Rowe Price Associates added most to Microsoft in Q3 2015, an estimated $1.57B increase.
- T. Rowe Price Associates's biggest Q3 2015 reduction was Baidu, cutting an estimated $1.76B.
- T. Rowe Price Associates fully exited HOSPIRA INC in Q3 2015, selling an estimated $988M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $449B portfolio in Q3 2015.
- T. Rowe Price Associates opened 86 new positions and closed 108 in Q3 2015.
- T. Rowe Price Associates's portfolio value fell 7.6% quarter-over-quarter to $449B.
Based on T. Rowe Price Associates's 13F filing for Q3 2015, filed 13 Nov 2015.